Laparoscopic sleeve gastrectomy (LSG) modifies the anatomy of the GI system, modulating nutrient transit and impacting gut physiology. The procedure is known to produce a long-term reduction in body weight and a decrease in the blood glucose level, both of which are relevant to obesity-related type 2 diabetes mellitus and cardiovascular disease. Some studies have pointed to the beneficial effect of surgery on the microbiotic diversity as a partial contribution to the resolution of the metabolic status of these patients [9] and subsequent improvement their QOL.
In this issue, Kazzi and her colleagues [10] focus on the possible effect of exogenous supplemental diet with probiotics and prebiotics after LSG on the QOL. This report suggests that surgical manipulation of the stomach during LSG may induce challenges within the bowel and investigated whether these may be alleviated by the use of probiotics and prebiotics. Although the study confirmed that bariatric surgery produces weight loss and improvement in comorbid conditions associated with obesity and of the QOL in all patients following surgery, it failed to show any significant difference in QOL between patients using prebiotics and those taking placebo for 3 months post operatively. Bariatric surgical intervention for weight loss, by itself, impacts the gut microbiota composition. Further trials are needed to draw conclusions about the role of microbial diversity in obesity.
